A Magnetic Resonance Imaging Contrast Agent Targeted Towards Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

A Magnetic Resonance Imaging Contrast Agent Targeted Towards Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

Bibliographic Details
Main Authors:	von Zur Muehlen, C, Elverfeldt, D, Moeller, J, Choudhury, R, Hagemeyer, C, Schwarz, M, Bode, C, Peter, K
Format:	Conference item
Published:	2008

Similar Items

Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis.
by: von zur Muhlen, C, et al.
Published: (2008)

A single-chain antibody directed against activated platelets allows targeted magnetic resonance imaging of human thrombi at clinically relevant field strengths
by: von zur Muhlen, C, et al.
Published: (2005)

Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.
by: von Zur Muhlen, C, et al.
Published: (2008)

Activated platelets canLiblilla be imaged by activation-specific glycoprotein IIb/IIIa antibodies conjugated to iron oxide microparticles in an ex vivo magnetic resonance imaging mouse model
by: von zur Muehlen, C, et al.
Published: (2007)

A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI.
by: von Zur Muhlen, C, et al.
Published: (2008)

An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide.
by: McAteer, M, et al.
Published: (2010)

Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa.
by: von zur Muhlen, C, et al.
Published: (2009)

Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosis: Interventional procedures guidance [IPG523]
by: National Institute for Health and Care Excellence, CA, et al.
Published: (2015)

Atherosclerosis and thrombosis: identification of targets for magnetic resonance imaging.
by: Choudhury, R
Published: (2007)

Ultrasound-enhanced thrombolysis using Definity as a cavitation nucleation agent.
by: Datta, S, et al.
Published: (2008)

Recent advances in photoacoustic contrast agents for in vivo imaging
by: Upputuri, Paul Kumar, et al.
Published: (2021)

Coronary thrombolysis.
by: Cairns, J, et al.
Published: (1989)

BENEFITS OF THROMBOLYSIS
by: Peto, R, et al.
Published: (1990)

Solid MRI contrast agents for long-term, quantitative in vivo oxygen sensing
by: Liu, Vincent Hok, et al.
Published: (2014)

Engineering genetically-encodable MRI contrast agents for in vivo imaging
by: Matsumoto, Yuri, Ph. D. Massachusetts Institute of Technology
Published: (2014)

Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease
by: Neal, Krista L., et al.
Published: (2016)

Attenuation of thrombosis by crude rice (Oryza sativa) bran policosanol extract: Ex Vivo platelet aggregation and serum levels of arachidonic acid metabolites
by: Wai, Teng Wong, et al.
Published: (2016)

Dual targeted microparticles of iron oxide detect endothelial adhesion molecule expression in mouse atherosclerosis by magnetic resonance imaging
by: McAteer, M, et al.
Published: (2006)

Does application of radio contrast media prior to thrombolysis impact thrombolytic effect in acute ischemic stroke?
by: Dzialowski, I, et al.
Published: (2008)

Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction.
by: Dall'Armellina, E, et al.
Published: (2012)

PRE-CONTRAST T1 MAPPING ALLOWS ASSESSMENT OF SEVERITY OF ACUTE ISCHAEMIC MYOCARDIAL INJURY
by: Dall'Armellina, E, et al.
Published: (2012)

Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.
by: Choudhury, R, et al.
Published: (2009)

Correlation of cavitation with ultrasound enhancement of thrombolysis.
by: Datta, S, et al.
Published: (2006)

Na-23-MRI allows non-invasive detection of the extent of sub-acute myocardial infarction without MR contrast agent in humans
by: Sandstede, J, et al.
Published: (2000)

Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging
by: Pellico, J, et al.
Published: (2019)

Porcine In Vivo Validation of a Virtual Contrast Model: The Influence of Contrast Agent Properties and Vessel Flow Rates
by: Peach, T, et al.
Published: (2016)

No-boarding buses: agents allowed to cooperate or defect
by: Saw, Vee-Liem, et al.
Published: (2024)

Superparamagnetic contrast agents for magnetic resonance imaging
by: Shen, Tueng
Published: (2006)

In vivo imaging with a cell-permeable porphyrin-based MRI contrast agent
by: Lee, Taekwan, et al.
Published: (2011)

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.
by: McAteer, M, et al.
Published: (2007)

Cerebral venous thrombosis: diagnostic accuracy of combined, dynamic and static, contrast-enhanced 4D MR venography.
by: Meckel, S, et al.
Published: (2010)

Magnetic resonance imaging contrast agents for chemical sensing
by: Liu, Vincent Hok
Published: (2014)

Target-specific contrast agents for magnetic resonance microscopy
by: Hepler Blackwell, Megan Leticia
Published: (2008)

Magnetic nanoparticles as contrast agents for magnetic resonance imaging
by: Chaughule, R. S., et al.
Published: (2013)

Organic/inorganic hybrid nanoparticulate resonant contrast agents
by: Kramberger, I
Published: (2016)

Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo.
by: Schäfer, A, et al.
Published: (2004)

Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease.
by: van Kasteren, S, et al.
Published: (2009)

Microparticle-Based Molecular MRI of Atherosclerosis, Thrombosis, and Tissue Ischemia
by: Mankia, K, et al.
Published: (2011)

Rapid regulation of platelet activation in vivo by nitric oxide.
by: Schäfer, A, et al.
Published: (2004)

Platelet PECAM-1 inhibits thrombus formation in vivo.
by: Falati, S, et al.
Published: (2006)